PSA RESPONSE TO NEOADJUVANT ANDROGEN DEPRIVATION THERAPY IS A STRONG INDEPENDENT PREDICTOR OF SURVIVAL IN HIGH-RISK PROSTATE CANCER IN THE DOSE-ESCALATED RADIATION THERAPY ERA

PURPOSE: The aim of the study was to evaluate the prognostic value of prostate specific antigen (PSA) response to neoadjuvant androgen deprivation therapy (ADT) prior to dose-escalated radiation therapy (RT) and long-term ADT in high-risk prostate cancer. METHODS AND MATERIALS: We reviewed the chart...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: McGuire, Sean E., Lee, Andrew K., Cerne, Jasmina Z., Munsell, Mark F., Levy, Lawrence B., Kudchadker, Rajat J., Choi, Seungtaek L., Nguyen, Quynh N., Hoffman, Karen E., Pugh, Thomas J., Frank, Steven J., Corn, Paul G., Logothetis, Christopher J., Kuban, Deborah A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3840533/
https://ncbi.nlm.nih.gov/pubmed/23102837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2012.08.036
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados